Moneycontrol » News » Business » Business News

Aurobindo receives 36th USFDA approval

Published on Fri, Jan 19, 2007 at 19:55 |  Source : Moneycontrol.com

Updated at Fri, Jan 19, 2007 at 20:09  

18212 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Aurobindo Pharm

BSE | NSE 10/02/12

Aurobindo Pharma Limited is pleased to announce that the company has received one more approval from the US FDA for Amoxicillin Tablets For oral suspension 200mg and 400mg.

 

Amoxicillin Tablets for oral suspension is a Beta-lactam antibiotic used often in treating respiratory infections. With this approval Aurobindo has its Amoxicillin approved by USFDA in four different formulations.

 

Sourced From: Aurobindo Pharma Limited

  

PREVIOUS STORY

To claim or not to claim - The HRA and Home loan dilemma!

NEXT STORY

Numeric Power Systems sells UPS business for Rs 837 cr

More on Moneycontrol
Headlines
view all »
Experts decode: Momentum with bulls, but book out or stay?
06:15 PM
Experts decode: Momentum with bulls, but book out or stay?
The week that was: Deal or no deal, mkt in for taxing times
07:47 PM
The week that was: Deal or no deal, mkt in for taxing times
Know Your Investment: Expert takes 'stock' of your stocks!
08:36 PM
Know Your Investment: Expert takes 'stock' of your stocks!
IEA cuts 2012 oil demand growth forecast yet again
06:16 PM
IEA cuts 2012 oil demand growth forecast yet again
Video of the day
'5200 strong support for mkt, next resistance at 5500-5550'
play
09:56 AM
'5200 strong support for mkt, next resistance at 5500-5550'
- in FII View
Sensex logs 6th week of gain, ends day with 85 pts loss
Listen Now!
Slideshows

Trending News

Business News

Tags: Aurobindo Pharma , US FDA , Amoxicillin Tablets , Beta-lactam , oral suspension , respiratory infections, approval
6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

News

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Explore Moneycontrol

STOCKS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
MUTUAL FUNDS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Unit Linked Insurance Plans (ULIPs) | | Budget: 2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | Union Budget | Budget 2012  | Economic Survey  | Railway Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide | History India  | Up Polls |  Latest News  | Uninor | Tata Steel | Aurobindo Pharma | DLF | Mahindra Satyam | Vodafone Essar | Reliance Industries | Mutual fund | Reliance Communications | IDFC
Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.